Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

EntreMed cleared to begin phase I trials of Endostatin protein

July 29, 1999

Irinotecan approved as first-line treatment for advanced colorectal cancer in Europe

July 29, 1999

Approval of Busulfex injection in Canada

July 29, 1999

Abbott signs paclitaxel agreement with NaPro BioTherapeutics

July 29, 1999

Novel epipodophyllotoxin derivatives with excellent antitumor activity

July 28, 1999

Asmarine A and B: novel cytotoxic alkaloids produced by marine organism

July 28, 1999

Kinetek initiates development of ILK and PKB inhibitors for cancer therapy

July 28, 1999

Bayer presents new anticancer compounds that inhibit Raf kinase

July 27, 1999

Paxene approved for E.U. marketing; Paxoral shows positive results in phase I

July 26, 1999

Valentis initiates phase I/II trial of IL-12 gene therapy

July 26, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...